AURA vs BIO · $406.7M cap vs rev $2.58B
Aura Biosciences Inc (AURA) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Aura Biosciences Inc (AURA) is a biotechnology company listed on US.
BIO (BIO) common stock.
AURA does not have a complete income-statement cache yet.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
AURA currently screens at market cap $406.7M. BIO currently screens at market cap $0.
Not investment advice. Open the AURA and BIO stock pages for the full models.
Not investment advice.